Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-032929
Filing Date
2013-06-05
Accepted
2013-06-05 16:46:59
Documents
1
Period of Report
2013-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd382262.html 4  
1 FORM 4 rrd382262.xml 4 3766
  Complete submission text file 0001181431-13-032929.txt   5151
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORP 717 PORTTER ST STE 100 BERKELEY CA 94710-2722
Business Address
DINA DINO (Reporting) CIK: 0001278709 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 13894759